# Aleeto in Acute ISchemic Stroke：A RandomISed Controlled Clinical Trial

Study · id `cardio:ct-nct06759753` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06759753](<https://clinicaltrials.gov/study/NCT06759753>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06759753

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 192 participants.

## Technical summary

Registry record NCT06759753. Randomized; double masking; primary purpose treatment. Start 2025-03-21 (actual); primary completion 2025-11-30 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 192 participants (planned count; ClinicalTrials.gov record NCT06759753, source copy `cardio:ctgov-nct06759753-2025-09-03`, retrieved 2026-10-26)
- Started: 2025-03-21 (actual) (ClinicalTrials.gov record NCT06759753, source copy `cardio:ctgov-nct06759753-2025-09-03`, retrieved 2026-10-26)
- Primary completion: 2025-11-30 (anticipated) (ClinicalTrials.gov record NCT06759753, source copy `cardio:ctgov-nct06759753-2025-09-03`, retrieved 2026-10-26)
- Completion: 2026-01-31 (anticipated) (ClinicalTrials.gov record NCT06759753, source copy `cardio:ctgov-nct06759753-2025-09-03`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT06759753, source copy `cardio:ctgov-nct06759753-2025-09-03`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06759753-2025-09-03`, retrieved 2026-10-26)

## The registry's words

- Brief title: Aleeto in Acute ISchemic Stroke：A RandomISed Controlled Clinical Trial
- Acronym: ASSIST
- Condition: Acute Ischemic Stroke
- Intervention (Drug): Aleeto
- Intervention (Drug): Placebo
- Lead sponsor: Beijing Tiantan Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: Beijing Tiantan Hospital (`cardio:org-beijing-tiantan-hospital`)

## Provenance

Content hash: 21b17eab773e71762d2ee281e972818c4168c03d0c5206813f83a76fdbd63cd2
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
